Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.62
(-0.36%)
HKD 16.62
(-0.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.05 Billion CNY | 2.25% |
| 2022 | 3.96 Billion CNY | 6.63% |
| 2021 | 3.71 Billion CNY | 27.6% |
| 2020 | 2.91 Billion CNY | -8.58% |
| 2019 | 3.18 Billion CNY | -7.33% |
| 2018 | 3.44 Billion CNY | 66.9% |
| 2017 | 2.06 Billion CNY | 36.71% |
| 2016 | 1.5 Billion CNY | 15.97% |
| 2015 | 1.3 Billion CNY | 9.05% |
| 2014 | 1.19 Billion CNY | 21.68% |
| 2013 | 980.04 Million CNY | 147.94% |
| 2012 | 395.27 Million CNY | 37.47% |
| 2011 | 287.53 Million CNY | 7.64% |
| 2010 | 267.11 Million CNY | 26.6% |
| 2009 | 210.98 Million CNY | 15.61% |
| 2008 | 182.49 Million CNY | -45.55% |
| 2007 | 335.14 Million CNY | 47.43% |
| 2006 | 227.32 Million CNY | 23.23% |
| 2005 | 184.48 Million CNY | 233.65% |
| 2004 | 55.29 Million CNY | -60.45% |
| 2003 | 139.79 Million CNY | -11.79% |
| 2002 | 158.47 Million CNY | 8.45% |
| 2001 | 146.13 Million CNY | -0.07% |
| 2000 | 146.23 Million CNY | 13.37% |
| 1999 | 128.98 Million CNY | 4.27% |
| 1998 | 123.7 Million CNY | 10.91% |
| 1997 | 111.52 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 609.41 Million CNY | 3.04% |
| 2024 Q2 | 591.44 Million CNY | -69.8% |
| 2024 Q1 | 1.95 Billion CNY | 640.51% |
| 2023 FY | 4.05 Billion CNY | 2.25% |
| 2023 Q2 | 902.64 Million CNY | -52.71% |
| 2023 Q3 | 980 Million CNY | 8.57% |
| 2023 Q1 | 1.9 Billion CNY | 287.8% |
| 2023 Q4 | 264.42 Million CNY | -73.02% |
| 2022 Q4 | 492.15 Million CNY | -44.35% |
| 2022 Q2 | 784.35 Million CNY | -56.56% |
| 2022 Q1 | 1.8 Billion CNY | 342.41% |
| 2022 FY | 3.96 Billion CNY | 6.63% |
| 2022 Q3 | 884.37 Million CNY | 12.75% |
| 2021 Q2 | 874.96 Million CNY | -46.24% |
| 2021 Q1 | 1.62 Billion CNY | 535.27% |
| 2021 Q4 | 408.13 Million CNY | -49.57% |
| 2021 Q3 | 809.36 Million CNY | -7.5% |
| 2021 FY | 3.71 Billion CNY | 27.6% |
| 2020 FY | 2.91 Billion CNY | -8.58% |
| 2020 Q3 | 894.79 Million CNY | 54.17% |
| 2020 Q4 | 256.17 Million CNY | -71.37% |
| 2020 Q1 | 1.18 Billion CNY | 3931.73% |
| 2020 Q2 | 580.4 Million CNY | -50.97% |
| 2019 Q2 | 1.14 Billion CNY | -18.92% |
| 2019 FY | 3.18 Billion CNY | -7.33% |
| 2019 Q1 | 1.4 Billion CNY | 83308.29% |
| 2019 Q3 | 611.95 Million CNY | -46.35% |
| 2019 Q4 | 29.36 Million CNY | -95.2% |
| 2018 Q2 | 1.71 Billion CNY | 89.34% |
| 2018 Q4 | 1.68 Million CNY | -99.79% |
| 2018 FY | 3.44 Billion CNY | 66.9% |
| 2018 Q1 | 905.16 Million CNY | 57.15% |
| 2018 Q3 | 820.29 Million CNY | -52.14% |
| 2017 Q3 | 327.51 Million CNY | -51.37% |
| 2017 FY | 2.06 Billion CNY | 36.71% |
| 2017 Q4 | 576 Million CNY | 75.87% |
| 2017 Q2 | 673.47 Million CNY | 38.96% |
| 2017 Q1 | 484.66 Million CNY | 7.32% |
| 2016 FY | 1.5 Billion CNY | 15.97% |
| 2016 Q1 | 409.31 Million CNY | 20.26% |
| 2016 Q2 | 422.48 Million CNY | 3.22% |
| 2016 Q3 | 224.61 Million CNY | -46.83% |
| 2016 Q4 | 451.61 Million CNY | 101.06% |
| 2015 Q2 | 409.89 Million CNY | 12.51% |
| 2015 FY | 1.3 Billion CNY | 9.05% |
| 2015 Q1 | 364.3 Million CNY | 8.54% |
| 2015 Q4 | 340.34 Million CNY | 84.21% |
| 2015 Q3 | 184.76 Million CNY | -54.92% |
| 2014 Q1 | 317.69 Million CNY | 26.18% |
| 2014 Q3 | 180.43 Million CNY | -49.31% |
| 2014 Q2 | 355.96 Million CNY | 12.05% |
| 2014 FY | 1.19 Billion CNY | 21.68% |
| 2014 Q4 | 335.62 Million CNY | 86.01% |
| 2013 FY | 980.04 Million CNY | 147.94% |
| 2013 Q1 | 153.18 Million CNY | 49.22% |
| 2013 Q2 | 434.04 Million CNY | 183.35% |
| 2013 Q4 | 251.78 Million CNY | 78.54% |
| 2013 Q3 | 141.02 Million CNY | -67.51% |
| 2012 Q3 | 75.53 Million CNY | -20.43% |
| 2012 Q1 | 122.15 Million CNY | 156.96% |
| 2012 FY | 395.27 Million CNY | 37.47% |
| 2012 Q4 | 102.65 Million CNY | 35.89% |
| 2012 Q2 | 94.93 Million CNY | -22.28% |
| 2011 Q2 | 92.64 Million CNY | 6.51% |
| 2011 Q3 | 60.37 Million CNY | -34.83% |
| 2011 Q4 | 47.53 Million CNY | -21.26% |
| 2011 FY | 287.53 Million CNY | 7.64% |
| 2011 Q1 | 86.98 Million CNY | 118.86% |
| 2010 Q1 | 68.29 Million CNY | 18.01% |
| 2010 Q3 | 58.59 Million CNY | -41.69% |
| 2010 FY | 267.11 Million CNY | 26.6% |
| 2010 Q4 | 39.74 Million CNY | -32.17% |
| 2010 Q2 | 100.48 Million CNY | 47.13% |
| 2009 Q1 | 37.79 Million CNY | 0.04% |
| 2009 FY | 210.98 Million CNY | 15.61% |
| 2009 Q4 | 57.86 Million CNY | 58.31% |
| 2009 Q3 | 36.55 Million CNY | -53.59% |
| 2009 Q2 | 78.76 Million CNY | 108.41% |
| 2008 FY | 182.49 Million CNY | -45.55% |
| 2008 Q4 | 37.77 Million CNY | 265.44% |
| 2008 Q3 | -22.83 Million CNY | -143.08% |
| 2008 Q1 | 114.26 Million CNY | -5.57% |
| 2008 Q2 | 53 Million CNY | -53.61% |
| 2007 Q3 | 55.73 Million CNY | -32.39% |
| 2007 FY | 335.14 Million CNY | 47.43% |
| 2007 Q1 | 77.84 Million CNY | 33.37% |
| 2007 Q2 | 82.43 Million CNY | 5.9% |
| 2007 Q4 | 121.01 Million CNY | 117.12% |
| 2006 Q1 | 68.39 Million CNY | 80.9% |
| 2006 Q4 | 58.36 Million CNY | 30.23% |
| 2006 FY | 227.32 Million CNY | 23.23% |
| 2006 Q3 | 44.81 Million CNY | -25.33% |
| 2006 Q2 | 60.02 Million CNY | -12.24% |
| 2005 Q4 | 37.8 Million CNY | -12.24% |
| 2005 Q3 | 43.08 Million CNY | -16.21% |
| 2005 Q2 | 51.41 Million CNY | -1.44% |
| 2005 Q1 | 52.17 Million CNY | 265.92% |
| 2005 FY | 184.48 Million CNY | 233.65% |
| 2004 Q3 | 9.22 Million CNY | 168.13% |
| 2004 Q1 | 28.36 Million CNY | 222.83% |
| 2004 FY | 55.29 Million CNY | -60.45% |
| 2004 Q4 | 14.25 Million CNY | 54.54% |
| 2004 Q2 | 3.44 Million CNY | -87.87% |
| 2003 Q1 | 52.35 Million CNY | 484.14% |
| 2003 Q2 | 41.25 Million CNY | -21.2% |
| 2003 Q3 | 37.39 Million CNY | -9.36% |
| 2003 FY | 139.79 Million CNY | -11.79% |
| 2003 Q4 | 8.78 Million CNY | -76.5% |
| 2002 Q1 | 51.96 Million CNY | 0.0% |
| 2002 Q4 | 8.96 Million CNY | -78.93% |
| 2002 Q3 | 42.54 Million CNY | -22.67% |
| 2002 Q2 | 55.01 Million CNY | 5.87% |
| 2002 FY | 158.47 Million CNY | 8.45% |
| 2001 FY | 146.13 Million CNY | -0.07% |
| 2000 FY | 146.23 Million CNY | 13.37% |
| 1999 FY | 128.98 Million CNY | 4.27% |
| 1998 FY | 123.7 Million CNY | 10.91% |
| 1997 FY | 111.52 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -3761.117% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | -115.728% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 2588.925% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 26511.036% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 7795.055% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -24188.41% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -1373.401% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 14161.223% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 3923.19% |
| SSY Group Limited | 1.31 Billion HKD | -207.571% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -3008.681% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -1419.163% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | -5.226% |